While we wipe away yet another tear for the never-ending demise of Brett Favre, there is some good news emanating from CDC:

Summary of Weekly FluView (http://www.cdc.gov/flu/weekly/summary.htm)

Meanwhile, IV peramivir seems to be an effective therapeutic agent for seasonal flu.  The study looked at a single intravenous dose of the neuraminidase inhibitor.  The drug reduced the duration of influenza (mostly H1N1 strain) symptoms when compared to placebo and was well tolerated  among 300 healthy outpatients with confirmed flu.  No serious side effects were noted.  The study involved healthy subjects, however.  So we really don’t know what the result would be for really sick  or chronically compromised flu patients.  Link to the abstract:  http://aac.asm.org/cgi/content/abstract/54/11/4568.

This entry was posted on Tuesday, November 23rd, 2010 at 1:40 am and is filed under Uncategorized.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or trackback from your own site.